Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1861)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (761)
Apply filters
Showing 761 to 770 of 1861
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroids
IPG704
25 August 2021
25 August 2021
Hysteroscopic metroplasty of a uterine septum for primary infertility
IPG509
23 January 2015
23 January 2015
Hysteroscopic metroplasty of a uterine septum for recurrent miscarriage
IPG510
23 January 2015
23 January 2015
Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation
TA429
25 January 2017
25 January 2017
Ibrutinib for treating relapsed or refractory mantle cell lymphoma
TA502
31 January 2018
31 January 2018
Ibrutinib for treating Waldenstrom's macroglobulinaemia
TA795
8 June 2022
8 June 2022
Ibrutinib for untreated chronic lymphocytic leukaemia without a 17p deletion or TP53 mutation (terminated appraisal)
TA452
5 July 2017
5 July 2017
Ibrutinib with bendamustine and rituximab for treating relapsed or refractory chronic lymphocytic leukaemia after systemic therapy (terminated appraisal)
TA437
22 March 2017
22 March 2017
Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal)
TA702
26 May 2021
26 May 2021
Ibrutinib with rituximab for treating Waldenstrom's macroglobulinaemia (terminated appraisal)
TA608
30 October 2019
30 October 2019
Previous page
1
…
75
76
Current page
77
78
79
…
187
Page
77
of
187
Next page
Results per page
10
25
50
All
Back to top